中东和非洲转染试剂和设备市场预测至 2030 年 - 区域分析 - 按产品(试剂和仪器)、方法(病毒方法、非病毒方法和混合方法)、应用(生物医学研究、蛋白质生产和治疗递送)和最终用户(学术和研究机构以及制药和生物技术公司)

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030


No. of Pages: 108    |    Report Code: BMIRE00030478    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Transfection Reagents and Equipment Market
2022 年,中东和非洲转染试剂和设备市场价值为 4615 万美元,预计到 2030 年将达到 8053 万美元;预计 2022 年至 2030 年的复合年增长率为 7.2%。

细胞和基因治疗日益普及,推动中东和非洲转染试剂和设备市场发展

细胞和基因治疗制造是一个复杂的过程,这使得其执行和监控至关重要。生物技术的进步导致采用个性化治疗方法治疗多种适应症。细胞和基因疗法主要用于治疗神经系统疾病、癌症和遗传疾病等慢性疾病。细胞和基因治疗的显著优势包括有针对性的治疗、更快更有效的恢复以及减少副作用。由于食品和药物管理局 (FDA) 批准的产品的可用性,细胞和基因疗法在世界范围内被广泛采用。例如,FDA 于 2022 年批准了 Ferring Pharmaceuticals A/S 生产的腺病毒 ADSTILADRIN。这种重组腺病毒 (rAd-IFNa/Syn3) 将人干扰素 alfa-2b cDNA 输送到膀胱上皮,用于治疗患有某些类型膀胱癌的患者。2022 年,Janssen Biotech, Inc. 生产的 CARVYKTI 也获得了 FDA 批准。CARVYKTI 是一种自体 CAR-T 细胞,经过慢病毒改造,可攻击表达 BCMA 的肿瘤细胞,用于治疗某些类型的复发或难治性多发性骨髓瘤。如今,科学家正在使用转染技术来生产这些疗法。因此,细胞和基因治疗活动普及度的激增推动了转染程序的数量,这反过来又推动了中东和非洲转染试剂和设备市场的增长。

中东和非洲转染试剂和设备市场概览

中东和非洲地区分为沙特阿拉伯、南非、阿拉伯联合酋长国和中东和非洲其他地区。沙特阿拉伯在 2022 年占有最大的市场份额。

中东和非洲制药业的增长在很大程度上受到跨国制药公司在沙特阿拉伯、南非、阿拉伯联合酋长国等国的投资推动。2023 年 1 月,沙特阿拉伯投资部签署了两份谅解备忘录,以加强与该国生物技术和医药行业的联合合作。该部与德国公司勃林格殷格翰签署了一项协议,以加强制药业。第二份谅解备忘录是与诺和诺德沙特阿拉伯和阿卜杜拉国王科技大学签署的,旨在为提高社区对代谢紊乱、肥胖和糖尿病概念的认识提供解决方案。这些让人们意识到罕见和慢性疾病的努力可能会在未来几年推动沙特阿拉伯的转染试剂和设备市场。

此外,这些国家公司之间的合作推动了市场增长,2021 年 12 月,Secondcell Bio 和 Alliance Care Technologies International 宣布建立新的战略合作伙伴关系,以建立一个新型的尖端研究机构,专注于细胞疗法和快速药物发现,以对抗阿联酋的罕见遗传病。Chromovert 技术远远领先于 CRISPR,它具有通过生成以前为改进药物发现而设计的细胞来简化药物发现过程的巨大潜力。

中东和非洲转染试剂和设备市场收入和预测到 2030 年(百万美元)

中东和非洲转染试剂和设备市场细分

中东和非洲转染试剂和设备市场根据产品、方法、应用、最终用户和国家/地区进行细分。

根据产品,中东和非洲的转染试剂和设备市场分为试剂和仪器。试剂部分在 2022 年占有较大的份额。

就方法而言,中东和非洲的转染试剂和设备市场分为病毒方法、非病毒方法和混合方法。非病毒方法部分在 2022 年占有最大份额。病毒部分细分为逆转录病毒、腺病毒、腺相关病毒和疱疹病毒。非病毒部分分为物理/机械方法和化学方法。此外,物理/机械方法部分细分为电穿孔、显微注射、基因枪法、激光法、磁转染和声穿孔。此外,化学方法部分细分为基于脂质体/高脂质和非基于脂质体/高脂质。

根据应用,中东和非洲转染试剂和设备市场细分为生物医学研究、蛋白质生产和治疗输送。生物医学研究部门在 2022 年占有最大份额。

根据最终用户,中东和非洲转染试剂和设备市场分为学术和研究机构以及制药和生物技术公司。学术和研究机构部门在 2022 年占有较大份额。

根据国家/地区,中东和非洲转染试剂和设备市场分为南非、沙特阿拉伯、阿联酋和中东及非洲其他地区。 2022 年,沙特阿拉伯在中东和非洲转染试剂和设备市场占据主导地位。

Thermo Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG 和 MaxCyte Inc 是中东和非洲转染试剂和设备市场的一些领先公司。

Middle East & Africa Transfection Reagents and Equipment Strategic Insights

Strategic insights for Middle East & Africa Transfection Reagents and Equipment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/middle-east-and-africa-transfection-reagents-and-equipment-market-strategic-framework.webp
Get more information on this report

Middle East & Africa Transfection Reagents and Equipment Report Scope

Report Attribute Details
Market size in 2022 US$ 46.15 Million
Market Size by 2030 US$ 80.53 Million
Global CAGR (2022 - 2030) 7.2%
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 产品
  • 试剂及仪器
By 方法
  • 病毒方法
  • 非病毒方法
  • 混合方法
By 最终用户
  • 学术机构
  • 研究机构以及制药和生物技术公司
Regions and Countries Covered 中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
Market leaders and key company profiles
  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Get more information on this report

    Middle East & Africa Transfection Reagents and Equipment Regional Insights

    The regional scope of Middle East & Africa Transfection Reagents and Equipment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/middle-east-and-africa-transfection-reagents-and-equipment-market-geography.webp
    Get more information on this report

    The List of Companies - Middle East & Africa Transfection Reagents and Equipment Market

    1. Thermo Fisher Scientific Inc
    2. Promega Corp
    3. F. Hoffmann-La Roche Ltd
    4. Bio-Rad Laboratories Inc
    5. Mirus Bio LLC
    6. QIAGEN NV
    7. Merck KGaA
    8. Lonza Group AG
    9. MaxCyte Inc

    Frequently Asked Questions
    How big is the Middle East & Africa Transfection Reagents and Equipment Market?

    The Middle East & Africa Transfection Reagents and Equipment Market is valued at US$ 46.15 Million in 2022, it is projected to reach US$ 80.53 Million by 2030.

    What is the CAGR for Middle East & Africa Transfection Reagents and Equipment Market by (2022 - 2030)?

    As per our report Middle East & Africa Transfection Reagents and Equipment Market, the market size is valued at US$ 46.15 Million in 2022, projecting it to reach US$ 80.53 Million by 2030. This translates to a CAGR of approximately 7.2% during the forecast period.

    What segments are covered in this report?

    The Middle East & Africa Transfection Reagents and Equipment Market report typically cover these key segments-

  • 产品 (试剂及仪器)
  • 方法 (病毒方法, 非病毒方法, 混合方法)
  • 最终用户 (学术机构, 研究机构以及制药和生物技术公司)
  • What is the historic period, base year, and forecast period taken for Middle East & Africa Transfection Reagents and Equipment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East & Africa Transfection Reagents and Equipment Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2030
  • Who are the major players in Middle East & Africa Transfection Reagents and Equipment Market?

    The Middle East & Africa Transfection Reagents and Equipment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Who should buy this report?

    The Middle East & Africa Transfection Reagents and Equipment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Middle East & Africa Transfection Reagents and Equipment Market value chain can benefit from the information contained in a comprehensive market report.